ProF-001
- Generic Name
- ProF-001
A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
Phase 2
Active, not recruiting
- Conditions
- Recurrent Vulvovaginal Candidiasis
- Interventions
- First Posted Date
- 2021-02-02
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- ProFem GmbH
- Target Recruit Count
- 432
- Registration Number
- NCT04734405
- Locations
- 🇦🇹
Universitätsklinik für Gynäkologie und Geburthilfe, Uni-Klinik IBK, Innsbruck, Tirol, Austria
🇵🇱Centrum Zdrowia Kobiety Komed,, Kielce, Poland
🇦🇹Ambulatorium für Pilzinfektionen und andere infektiöse venero-dermatologische Erkrankungen, Wien, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath